We have shown that in mouse models of CRC the molecular mechanism by which normal levels of RPL24 maintain translation is via eEF2K and P-eEF2, therefore implicating this pathway in these previously studied blood cancer models. This evidence concerns the gene RPL24 and hematopoietic and lymphoid system neoplasm.